RE:RE:RE:flynn/Pfizer - end of monthIt's government, they move slow, take their time and the more evidence they gather, the longer it takes.
AMCo will be easy for them, would not be surprised they make an exception for this one. The papertrail is huge. The drugs have been flipped and jacked up so much, and the "reformulation" of meds in different form factors and relabels to generic to avoid brand name caps from NHS, will crucify AMCo and, most important those who holder the debt. CXR shareholders!
https://www.gov.uk/government/organisations/competition-and-markets-authority
puma1 wrote: Everything said a September comment date. A delay hurts but the tone of earlier statements by the body never hinted of a delay.
LaticelnExile wrote:
puma1 wrote:
the CMA decision is expected this week and if they do go ahead with their earlier position and levy a large fine against the parties for drug price inflation, this stock will take a large hit imo.
I now have the decision date on this expected pushed to November 2016.